Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02999633
Title Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia (ISLAY)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Indications

T-cell adult acute lymphocytic leukemia

childhood T-cell acute lymphoblastic leukemia

Therapies

Isatuximab

Age Groups: child | senior | adult
Covered Countries USA | ITA | FRA


No variant requirements are available.